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ABSTRACT
Context: Cola gigantea A. Chev. (Sterculiaceae) is an important medicinal tropical flora.
Objective: The seed oil of C. gigantea, an underutilized tropical plant was investigated for its antioxidant,
anti-inflammatory, anti-Toxoplasma, and cytotoxicity activities as well as the chemical composition.
Materials and methods: The physicochemical parameters of the seed oil obtained via Soxhlet extraction
was determined while the fatty acid and non-fatty acid component were analyzed by gas chromatog-
raphy-mass spectrometry. The antioxidant activity was evaluated using 2,2-diphenyl-1-picrylhydrazyl
(DPPH) and 2,2-azino-bis-(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) assays (10–50mg/mL) while the
anti-inflammatory property was determined through Cell Membrane Stabilization assay. The anti-parasite
and cytotoxicity activity were evaluated (0–1000mg/mL) using Toxoplasma gondii and mammalian cell line
assays, respectively.
Results: The oil had fatty acids which ranged from C-12 to C-23 with linoleic (18:2) and palmitic acids
(16:0) being dominant. The oil had 89.41% unsaturated fatty acids with sterolic acid, an uncommon acety-
lenic fatty acid reported for the first time. Non-fatty acids obtained include cholesterol (2.12%), campes-
terol (14.12%), stigmasterol (34.07%) and b-sitosterol (49.68%). The oil had a significantly (p< 0.05) low
scavenging activity against DPPH radicals (IC50> 50mg/mL) compared with ascorbic acid. In contrast, the
oil showed better activity against ABTS radicals (IC50 44.19±6.27mg/mL) compared with ascorbic acid or
quercetin. Furthermore, the oil showed anti-T. gondii and dose-dependent cytotoxicity in HFF cells with
selectivity index (IC50/EC50< 1).
Discussion and conclusions: The antioxidant potential of the oil suggests that it may serve as a potential
source for various preparations for pharmaceuticals and cosmeceuticals.
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Introduction
Cola gigantea A. Chev. (Sterculiaceae), commonly known as
giant Cola, is found mostly in relatively dry parts of the rain for-
est of the West Africa and West Indies (Olorode, 1984). The
mature fruit of Cola species is a nut known as Kolanut (Duke
2001). It is an ever-green moderately sized tree often growing to
a height of 25m with glossy ovoid leaves up to 25 cm. Extracts
of the plant are reported to have significant antimicrobial activity
against a series of bacteria and fungi (Adeniyi et al. 2004; Reid
et al. 2005; Sonibare et al. 2009; Agyare et al. 2012; Onyema and
Ajiwe 2014). The leaf extracts are also acclaimed to boost blood
supply, cure anaemia, sores, skin infection, and other inflamma-
tory conditions. The nuts have a bitter flavour and high caffeine
content (Benjamin et al. 1991; Blades 2000) and are often used
for treatment of whooping cough, asthma, malaria, and fever
(Odugbemi 2006). Additionally, the plant has other traditional
relevance among which are the uses for increasing the capacity
for physical exertion and enduring fatigue without food, stimula-
tion of weak heart, and treating nervous debility, lack of emo-
tion, depression, despondency, brooding, anxiety, and sea-
sickness (Agyare et al. 2012). Phytochemical screening of the leaf
extract indicated the presence of alkaloids, saponins, tannins,
anthraquinones, and cardenolides (Sonibare et al. 2009). These
phytochemicals might be responsible for the observed medicinal
properties of the plant.
However, the chemical composition and corresponding bio-
logical profiling of the seed of C. gigantea have not been
explored. This study reports for the first time the chemical com-
position, physicochemical properties, antioxidant, anti-inflamma-
tory, anti-parasite and potential of the seed oil of C. gigantea.
Materials and methods
Plant material
C. gigantea seeds were obtained during winter of 2012 in Ogun
State, Nigeria. The sample was identified by a renowned botanist,
Mr. Bolu Ajayi, at the Herbarium of the Biological Sciences
Department of the University of Ilorin, Ilorin, Nigeria. The seeds
were removed from the fruit of C. gigantea, dried at room tem-
perature, and pulverized. Pulverized seed material (710 g) was
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subjected to Soxhlet extraction using hexane for 3 h and the
extract concentrated to obtain the oil.
Preparation of sterol constituents for analysis
The oil (100mg) was extracted with 10mL saponification reagent
[ethanol:33% KOH (w/v):20% ascorbic acid (94:6:0.5)]. 5a-
Cholestane (100lL) at a final concentration of 10 ppm was
added as internal standard. The mixture was vortexed and subse-
quently incubated for 60min at 50 C. After the sample was
cooled in ice water for 10min, 5mL deionized water and 5mL
hexane were added and the sample was vortexed and left to
allow for separation into phases. The supernatant phase
(1000 mL) was then dried in a speedvac. The dry samples were
reconstituted with 200mL dichloromethane and derivatized with
200mL pyridine followed with 100mL BSTFA and 1% TCMS.
The mixture was vortexed and incubated for 1 h in an oven
maintained at 50 C. After incubation, the mixture was again
vortexed and then transferred into a vial with an insert.
Preparation of fatty acid methyl esters (FAMEs)
The oil was subjected to trans-esterification by treating 2 g of the
oil with 10mL 0.2M methanolic H2SO4 following standard pro-
cedure (Atolani et al. 2016). The mixture was refluxed for an
hour and then allowed to settle down. The organic phase con-
taining the fatty acid methyl esters (FAMEs) was obtained using
the separating funnel and thereafter concentrated via distillation.
The FAMEs obtained was dried over anhydrous magnesium sul-
fate and kept for Gas Chromatography-Mass Spectrometry (GC-
MS) analysis.
Determination of saponification value
Saponification value was determined as described elsewhere
(Fakhri and Qadri 2011; Atolani et al. 2016). Briefly, an aliquot
of the oil (0.2 g) was taken in a conical flask and mixed with
25mL methanolic sodium hydroxide (NaOH) plus three (3)
drops of phenolphthalein indicator. The solution was thoroughly
mixed, cooled in an ice bath and then titrated against 0.5M HCl
until the pink colour disappeared. The saponification value was
thereafter estimated using the equation:
SV ¼ Volume of SBð Þ M  56:1
g
mol
 
Weight of sample gð Þ ¼
mgKOH
g
where B¼ blank titer value (mL); S¼ sample titer value (mL);
M¼Molarity of KOH.
Determination of acid value
Oil (0.2 g) was dissolved in 25mL methanol and the mixture
warmed in a water bath for 5min with occasional shaking. Three
drops of phenolphthalein indicator were added and the solution
titrated against with 0.1M NaOH, until the pink colouration dis-
appears. The same procedure was followed for blank but without
the sample (Atolani et al. 2016). The acid value was thereafter
estimated using the expression:
AV ¼ Volume of KOHð Þ  N  56:1 g=mol
Weight of sample gð Þ ¼
mgKOH
g
where AV¼Acid value; M¼Molarity of KOH
Antioxidant activities
The antioxidant capacity of the oil was established by using two
complimentary antioxidant assays; the 2,2-diphenyl-1-picrylhy-
drazyl (DPPH) and 2,2 azino-bis-(3ethylbenzothiazoline-6-sul-
phonic acid) (ABTS) scavenging assays.
2, 2-Azinobis-3-ethylbenzothiazoline-6-sulfonate (ABTS)
scavenging assay
The ABTS assay was carried out as described previously (Atolani
et al. 2013; 2018; Kambizi et al. 2017). Briefly, 7mM ABTS in
deionized water was mixed at ratio 1:1 with freshly prepared
potassium persulfate (2.45mM) and the mixture kept in the dark
for 24–48 h. The ABTS solution was diluted in methanol at 1:25.
Aliquot (20lL) of samples (10–50mg/mL) was added to 2mL of
ABTSþ solution, and the mixture kept at a standard temperature
of 30 C. The absorbance was measured at 734 nm at 10min after
initial mixing. All analysis was determined in triplicate. The %
ABTS scavenging activity was calculated against the control by
using the expression:
Antioxidant Capacity; AOC ¼ ½ðAcontrol–AsampleÞ  100=ðAcontrolÞ
where Acontrol and Asample represent the absorbances of the con-
trol and the samples, respectively.
2, 2-Diphenyl-1-picrylhydrazyl (DPPH) Free radical
scavenging assay
The DPPH assay was carried out following a previously
described protocol (Atolani et al. 2013; 2015). The DPPH reagent
was freshly prepared and kept in a dark bottle in the refrigerator
overnight. The standard antioxidant (ascorbic acid) and extracts
were prepared in triplicate at between 10–50 mg/mL. Aliquot
(1mL) of DPPH solution was added to all samples and this fol-
lowed immediately by incubation in the dark for 30min. The
absorbance value was measured at 517 nm and the % antioxidant
activity was estimated against the control using the expression:
Antioxidant Activities; AA ¼ Acontrol–Asampleð Þ  100½ = Acontrolð Þ
where Acontrol and Asample represent the absorbances of the con-
trol and the samples, respectively.
Anti-Inflammatory (red blood cell membrane
stabilization) Assay
The procedure described previously for estimating anti-inflam-
matory potential (Kambizi et al. 2017) was adopted. Mice were
kept for 2 weeks without any contact with nonsteroidal anti-
inflammatory drugs. Thereafter, blood samples were collected
from the mice mixed with equal volume of Alsever solution (2%
dextrose, 0.8% sodium citrate, 0.5% citric acid and 0.42% NaCl).
The mixture was subjected to centrifugation at 3000 rpm to
obtain packed cells which were washed with isosaline solution
and a 10% portion of the suspension was reconstituted with nor-
mal saline. Hyposaline solution (2mL), 0.5mL RBC suspension
and 1mL phosphate buffer was added to the extracts or diclofe-
nac (reference drug) prepared in triplicate in distilled water at
different concentrations (50 and 100 mg/mL). The mixture was
incubated at 37 C for 30min and thereafter the mixture
was centrifuged at 3000 rpm for 20min. Then the absorbance
was recorded at 560 nm and the extent of the stabilization was
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estimated by using the formula:
Stabilizationð%Þ ¼ 100ðAt=AcÞ  100
where At and Ac are the respective absorbance of the test sam-
ples and the control.
In vitro anti-parasite assay
The T. gondii RH strain 2 F (ATCCVR 50839) was used for the
anti-parasite study. The parasite was maintained by repeated pas-
sages in HFF cells cultured in DMEM (Nissui, Tokyo, Japan)
and supplemented with GlutaMAXTM-I (Gibco, Invitrogen, UK),
10% (v/v) fetal calf serum (FCS; Gibco, Invitrogen, UK), and
penicillin and streptomycin (100U/mL; Biowhittaker, UK). HFF
cells infected with T. gondii tachyzoites were passed through a
27-gauge needle to lyse them. The cell lysates were then filtered
through a 5mm filter to obtain a tachyzoite suspension free of
host cell debris. The parasite suspension was washed with fresh
culture medium and the in vitro parasite growth inhibition
assays were performed as previously described (Adeyemi et al.
2017). Briefly, the oil extracts (reconstituted in culture medium)
were incubated with freshly lysed and purified parasites in grow-
ing HFF cells in 96-well optical bottom plates (Nunc; Fisher
Scientific, Pittsburgh, USA). Medium-treated cells served as
negative drug control. Sulfadiazine was included a positive drug
control. After 72 h incubation at 37 C in a 5% CO2 atmosphere,
the viability of the RH-2F parasite strain was determined by
assaying for galactosidase activity by using a B-Glo luminescent
assay kit (Promega, Madison, USA). The assay was performed in
triplicate and repeated three times.
Measurement of intracellular reactive oxygen species (ROS)
Measurement of intracellular ROS was as previously described
(Adeyemi et al. 2017). This is premised on the intracellular per-
oxide-dependent oxidation of 20,70-dichlorodihydro-fluorescein
diacetate (H2DCF-DA, Sigma, St. Louis, MO, USA) to form the
fluorescent compound 20,70-dichlorofluorescein (DCF). Briefly,
growing HFF monolayers were treated with C. gigantea in the
absence/presence of T. gondii infection. After 24 h incubation at
37 C and 5% CO2 atmosphere, the cells were harvested, purified,
and re-suspended in PBS containing the H2DCF-DA to a final
concentration of 100mM. The cell suspension containing the
fluorescent dye was incubated for 30–60min at 37 C.
Fluorescence acquisition was recorded by using a spectrofluor-
ometer (Corona Electric, Japan) with excitation set at 485 nm
and emission at 530 nm. H2O2 was included as a positive control
in order to validate the ROS detection assay.
Measurement of the mitochondrial membrane
potential (MMP)
The measurement of MMP was as described elsewhere (Adeyemi
et al. 2017). Briefly, growing HFF cells were treated with C.
gigantea oil in the absence/presence of T. gondii infection. After
24 h incubation at 37 C and 5% CO2 atmosphere, the cells were
harvested, purified, and stained with 200 nM MitoRed (Dojindo
Molecular Technologies Inc. Japan) by following the manufac-
turer’s protocol. Fluorescence measurement was acquired by
using a spectrofluorometer (Corona Electric, Japan) with excita-
tion set at 560 nm and emission at 580 nm.
Cytotoxicity of the oil in mammalian cell
Human foreskin fibroblast (HFF, ATCCVR ) cells were maintained
in normal cell culture medium (DMEM, GlutaMAXTM-I, 10%
(v/v) fetal calf serum and penicillin and streptomycin. Confluent
cells were harvested as per sub-culture protocol and re-sus-
pended to the desired cell density. The cells were seeded onto
96-well plates (Nunc; Fisher Scientific, Pittsburgh, USA) at a
density of 1 105 cells per well and incubated for 72 h followed
by treatment with various concentrations (0–1000 mg/mL) of the
oil extracts. Culture medium lacking the test compounds was
added to the control well Staurosporine was included as positive
drug control. After 72 h incubation at 37 C and 5% CO2 atmos-
phere, the cell viability was determined by using the CellTitre-
Aqueous One Solution proliferation assay kit (Promega,
Madison, USA) and following the manufacturer’s instruction.
The absorbance signal was recorded at 490 nm by using a micro-
plate reader (MTP 500; Corona Electric, Japan). The assay was in
triplicates and repeated three times independently.
GC-MS analysis of sterol constituents
Chromatographic separation of the compounds was performed
on a gas chromatograph. Aliquot (1mL) of the sample was
injected into an Agilent 6890N (Agilent, Palo Alto, CA) coupled
to an Agilent 5975MS mass spectrometer detector, using a
Zebron AB-MultiResidue II (30 by 0.25mm ID, 0.25mm film
thickness) column (Part No. 7HG-G016-11). The oven tempera-
ture program was maintained at 100 C for 2min, ramped at
15 C/min to 180 C held for 0min, ramped at 5 C/min to 250
and held for 3min and finally at 20 C/min to 320 C held for
12min. The total run time was 40min. The carrier gas was
helium at a flow rate of 1.2mL/min and the injector temperature
was maintained at 200 C and operated in a splitless mode. The
Mass spectral data were recorded on a MSD operated in full
scan mode (35–600m/z) with both the ion source and quadruple
temperatures maintained at 240 C and 150 C, respectively. The
transfer line temperature was maintained at 200 C. Solvent
Delay was held at 5.00min. The compounds were identified on
the basis of fragment pattern obtained and comparison of the
retention time with that of authentic samples injected.
GC-MS analysis of FAMEs
The FAMEs obtained from the seed oil of C. gigantea were ana-
lyzed on gas chromatograph GC QP2010SE SHIMADZU, Japan,
equipped with a silica capillary HP-5MS column (30m by 0.32,
0.5 mm) coupled directly to a mass detector (Agilent Technology
MSD). Helium served as the carrier gas. The injector was oper-
ated at 250 C and while the detector was operated at 380 C.
The oven temperature was programmed to rise from 40 to
250 C at a heating rate of 5 C/min. The analyses were per-
formed using a split mode (1:10). Scan start time-end time;
3.77–29.31min. The instrument was calibrated using authentic
samples of n-alkanes for the reliability of characterization of
compounds. The mass range of the mass spectrometer was set to
45–650m/z. The FAMEs were identified on the basis of the
authentic samples previously injected in combination with the
examination with individual molecular weight, mass spectra and
comparison of fragmentation pattern in the mass spectrum with
that of the National Institute of Science and Technology,
NIST library.
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Data analysis
Results were analyzed by using a one-way ANOVA (GraphPad
Software Inc., San Diego, CA, USA) and data are presented as
the mean ± standard error of mean (SEM) except otherwise indi-
cated. All experiments were performed in triplicate. The concen-
tration of the oil showing a 50% inhibition or reduction in
parasite and/or cell viability (i.e., IC50 values) were estimated
from a dose-response curve while a non-linear regression ana-
lysis was used to fit the curve. Values at p< 0.05 were taken as
significant.
Results and discussion
Physicochemical characterization
The physico-chemical characteristics of the seed oil of C. gigan-
tea are shown in Table 1. The oil had saponification value of
45.623mg KOH/g. This value was considerably low considering
its potential for industrial purposes (such as soap manufacture)
and the suitability for human consumption. According to Codex
Standards for Edible Fats and Oils, the maximum level of acid
value permitted for refined fats and oils is 0.6mg KOH/g fat or
oil. The acid value recorded for C. gigantea in this study is
0.25mg/g. The acid value of the oil is within a range acceptable
for edible purposes. The low acid value of oil is an indication for
stability over a long period of time. The low acid value of the oil
also reveals that the oil would be less susceptible to rancidity.
Antioxidant activities
The antioxidant activities of the oil were examined using the
DPPH and ABTS assays. The extent of ABTS radical scavenging
activity of the oil compared to the reference compound, quer-
cetin is as depicted (Supplementary data 1). The oil had a dose-
response ABTS radical scavenging activity with highest activity
observed at the highest concentration (50mg/mL) tested. ABTS
radical scavenging activity (Table 2) of C. gigantea oil (IC50¼ 44.
19 ± 6.27 mg/mL) indicated that the oil has good antioxidant
potential although not significant (at p< 0.05) when compared
to quercetin (IC50¼ 75.14 ± 4.32mg/mL).
The percentage DPPH radical scavenging activity of C. gigantea
seed oil, examined by dose-response, was lower than the reference
compound, ascorbic acid (Supplementary data 2). The highest
activity of 44.52% was recorded at the highest concentration,
50mg/mL meaning the IC50 value was >50mg/mL (Table 2). This
suggests that the oil had low scavenging activity for DPPH radical
compared with ascorbic acid.
Anti-inflammatory potential
The anti-inflammatory activity of C. gigantea seed oil was evaluated
through cell membrane stabilization assay. The oil does not clearly
exhibit a dose-response activity as compared to the standard,
Table 1. The physiochemical characteristics of the oil.
Parameters Value
Colours Yellow
% yield of soxhlet oil (w/w) 1.0
% yield of the trans-esterified oil (w/w) 30.37
Saponification value (mgKOH/g) 45.63
Acid value (mgKOH/g) 0.2 5
Table 2. IC50 values of the radical scavenging activity of the seed oil.
IC50 (mg/mL) Ascorbic acid Quercertin C. gigantea seed oil
ABTS 75.15 ± 4.32 76.71 ± 0.40 44.19 ± 6.27
DPPH 13.55 ± 0.56 ND 50
ND: Not determined. Data are expressed as Mean ± Standard Error of Mean of
triplicate determinations. Values are Significant at p< 0.05.
Figure 1. Membrane stabilization potential of C. gigantea seed oil.
Table 3. Fatty acids composition of C. gigantea seed oil.
S/N RT (Min) Name of Compound Mol. Formula % Composition
1 8.84 Lauric acid C12H24O2 0.65
2 10.72 Myristic acid C14H28O2 0.39
3 12.95 Palmitic acid C16H32O2 20.26
4 13.49 Stearolic acid C18H32O2 11.69
5 13.86 9,12-Hexadecanoic acid C16H28O2 13.45
6 14.11 Linoleic acid C18H32O2 40.67
7 14.33 Stearic acid C18H36O2 9.33
8 15.04 10-Nonadecenoic acid C19H36O2 3.34
9 17.50 Tricosanoic acid C23H46O2 0.22
Total Saturates 10.59
Total Unsaturates 89.41
Parasite viability 72 hpi
200 400 600 800 1000
0
50
100
150
Control C. gigantea
μg/ml
R
el
at
iv
e
Pa
ra
si
te
 V
ia
bi
lit
y 
(%
)
Figure 2. Anti-Toxoplasma gondii activity of C. gigantea oil.
Table 4. Chemical composition of the non-fatty acids constituent of C. gigantea
seed oil.
S/N Retention Time (Min) Sterol Relative Abundance (%)
1 28.82 Cholesterol 2.12
2 29.54 Campesterol 14.12
3 29.76 Stigmasterol 34.07
4 30.26 Beta-Sitosterol 49.68
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diclofenac (Figure 1). The IC50 value of the oil (0.23±3.30mg/mL)
reveals that the oil exhibited good anti-inflammatory property in
membrane stabilization of red blood cell.
Fatty acids profile of C. gigantea seed oil
The GC-MS analysis of the trans-esterified seed oil of the C.
gigantea revealed the presence of nine fatty acids (Table 3). The
major fatty acids are linoleic acid (40.67%), palmitic acid
(20.26%), 9,12-hexadecanoic acid (13.45%), stearolic acid
(11.69%) and stearic acid (9.33%). Other fatty acids were
obtained in minute quantities. The oil had 89.41% unsaturated
fatty acids with sterolic acid accounting for 13.07% of the total
unsaturated content. The stearolic acid (18:2) also known as 9-
octadecynoic acid is an uncommon acetylenic fatty acid sug-
gested to be an important fatty acid with novel DNA binding
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Figure 3. (A,B) Anti-T. gondii activity of C. gigantea in the absence/presence of a-tocopherol (Trolox). Values are expressed as the Mean± SEM (n¼ 3). Each experi-
ment was in triplicates and performed three times independently. c is significant at p< 0.0001 versus control.
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Figure 4. ROS level and mitoRed fluorescence intensity following 24 h treatment with C. gigantea; (A) In the absence of T. gondii infection; (B) In the presence of T.
gondii infection; (C) In the absence of T. gondii infection; (D) In the presence of T. gondii infection. Values are expressed as the Mean± SEM (n¼ 3). Each experiment
was done in triplicates and performed three times independently. c is significant at p< 0.0001 versus control.
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capacity (Thomasson 1954; Berry et al. 1991). It is reported to be
present in the seeds of Olacaceae and Santalaceae families
(Okada et al. 2013). An odd number fatty acid (10-nonadecenoic
acid, 19:1) was obtained in small quantity. Linoleic (18:2) and
palmitic acids (16:0) were the dominant and sub-dominant fatty
acids in the oil, implying that C. gigantea can be a good source
of edible.
Sterol composition of the C. gigantea seed oil
The sterol composition in the seed oil of C. gigantea was deter-
mined following standard procedure. The quantitative GC-MS
results indicated the presence of four sterols which include choles-
terol, campesterol, stigmasterol and b-sitosterol at 2.12, 14.12, 34.07
and 49.68%, respectively (Table 4 and Supplementary data 3).
b-Sitosterol was apparently the most abundant sterol in the seed.
In vitro anti-parasite potential
The in vitro anti-parasite assay was carried out in order to evalu-
ate the potency of C gigantea oil to inhibit the parasite growth
using the T. gondii as a proof-of-principle. The oil showed
dose-dependent action against T. gondii (Figure 2); the lowest
concentration had the highest cell viability. The anti-parasite of
C gigantea is significantly high when compared with the negative
drug control thus suggesting that C gigantea seed oil can be
explored as alternative anti-parasite agent.
Addition of Trolox failed to abate the anti-parasitic activity
of C. gigantea oil
The reactive oxygen species (ROS) was determined in order to
show whether ROS was culpable in the anti-parasite action of
the C. gigantea oil. An antioxidant, Trolox (100mM) was
included in the screening assay and data showed that the add-
ition of Trolox failed to relieve the parasite growth restriction
capability of the C gigantea (Figure 3(A,B)). This suggests that
oxidative stress might not be contributing to the anti-parasite
action of the oil extract.
Probably, C. gigantea did not predispose to the generation of
ROS but utilizes alternative ways to restrict parasite growth.
Moreover, data revealed that the C. gigantea oil extract actually
reduced the ROS level by 70% when compared with the nega-
tive drug control (Figure 4(A,B)). This is thus suggesting that the
C. gigantea oil extract might possess some level of antioxidant
capacity and further confirmed the in vitro antioxidant potential
as determined in this study. In contrast, we found that the C.
gigantea oil extract mildly affected the cellular MMP (Figure
4(C)) but not in the presence of T. gondii infection (Figure
4(D)). The reason for this is unknown but may further support
the fact the anti-parasite action of the C. gigantea oil extract pre-
cludes oxidative stress. Consequently, the C. gigantea oil also
reduced cellular mitochondria membrane potential (MMP) in
the absence of the T. gondii infection (Figure 4(C)), but not in
the presence of the T. gondii infection (Figure 4(D)). This prob-
ably might be due to alteration of physiological status of cells
due to T. gondii infection.
Cytotoxicity of oil extracts in mammalian cells
Here, the cytotoxic action of the C. gigantea in HFF cells was
determined. Data showed that the C. gigantea oil extract exhib-
ited dose-dependent cytotoxic action against the HFF monolayers
(Figure 5).
Selectivity index (SI)
In order to determine the anti-parasitic efficacy of the C. gigan-
tea oil, we estimated the SI of the oil which is the ratio of the
cytotoxicity (IC50) in host cells to the anti-parasite activity
(EC50). Data revealed that C. gigantea had SI of 	1 relative to
the reference drug, sulfadiazine, (SI 	 4), the drug currently
used for treatment of toxoplasmosis (Table 5). C. gigantea oil
failed to show promising specific anti-parasitic activity which
may indicate that the anti-parasitic activity of it might be due to
general cellular toxicity.
Conclusions
The chemical constituent of C. gigantea seed has been investi-
gated. The GC-MS analysis revealed the presence of 12 fatty
acids of which palmitic and stearolic acids were the dominant
fatty acids. Four sterols, namely cholesterol, campesterol, stig-
masterol, and b-sitosterol were detected and quantified. Our data
showed that the C. gigantea oil extract possesses mild antioxidant
as well as an anti-inflammatory potential. Further, data suggest
that the anti-parasite action of the C. gigantea oil extract might
be as a result of general cellular toxicity and that this toxic effect
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Figure 5. Cell viability of C. gigantea oil using HFF monolayers. Cell viability val-
ues were calculated relative to background values (0% viability) and the
untreated negative control (100% viability). Staurosporine (1mM) was included as
positive control to validate the assay. Values are expressed as the Mean± SEM
(n¼ 3). Each experiment was in triplicates and performed three times
independently.
Table 5. Selectivity Index of C. gigantea seed oil.
Sample Anti-parasite activity EC50 (mg/mL) Host cell cytotoxicity IC50 (mg/mL) Selectivity index: IC50/EC50
C. gigantea 	15 	10 <1
Sulfadiazine 	150 	500 <4
ND: Not determined. Data are expressed as Mean ± Standard Error of Mean of triplicate determinations. Values are
Significant at p< 0.05.
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precludes ROS production and/or oxidative stress. Overall, data
shows the bio-activity potential of the oil from the underutilized
seed has significant capacity for application in foods and cosmet-
ics. The potential in the seed could be cheaply harnessed for
future chemical and biochemical applications.
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